Navigation Links
Debiopharm and EPFL Sign Research Project Agreement to Identify Inhibitors of Signalling Pathways Controlling Cell Fate for Cancer Treatment
Date:9/2/2008

LAUSANNE, Switzerland, September 2 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist focusing on serious medical conditions and particularly oncology, today announced the signature of a research project with the Ecole Polytechnique Federale de Lausanne (EPFL), aimed at the identification of novel small molecules and peptides that interfere with pathways controlling cell fate specification. The project, named Debio 0826, could lead to the development of potential therapeutic compounds and to the identification of new targets to fight cancer stem cells.

Following the signature of an EPFL-Debiopharm partnership on February 12, this first joint research project will be performed under the supervision of Dr. Freddy Radtke, Associate Professor at the Swiss Institute for Experimental Cancer Research (ISREC) and Dr. Gerardo Turcatti, MER, Director of the Biomolecular Screening Facility (BSF), two groups at the EPFL. Debio 0826 will benefit from the multiple molecular and genetic tools generated by Dr. Radtke's group over the past 10 years, as well as the expertise of Dr. Turcatti in the molecular screening field.

"Targeting pathways controlling cell fate specification could generate innovative anti-cancer drugs with anti-tumoural, anti-metastatic and anti-angiogenic properties to treat tumours that are currently resistant to standard therapies," said Kamel Besseghir, CEO of Debiopharm S.A.

About Debiopharm Group

Debiopharm Group is a global biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug candidates. Debiopharm develops its products for global registration and maximum commercial potential for out-licensing to pharmaceutical partners for sales and marketing. Debiopharm independently funds the worldwide development of all of its products while providing expertise in pre-clinical and clinical trials, manufacturing, drug delivery and
'/>"/>

SOURCE Debiopharm Group
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
3. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
4. Researchers at Cleveland Clinic Identify Site of Dysfunction in HDL, Carrier of Good Cholesterol
5. Video: New Research Discovers Independent Brain Networks Control Human Walking
6. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
7. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
8. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
9. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
10. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
11. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...e-FirstCall/ -- Virtual Health Technologies, Inc. ...e previously confirmed Letter of Intent to sell al...echnologies, Inc (WNDM) is subject to final approv...VHGI. ,, Shareholder Assurances ,, "We b...stream and cash realized from the transaction woul...
(Date:11/6/2009)...stCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA ...ent of small-molecule therapeutics for the treatme...s (HIV), today reported recent accomplishments and...months ended September 30, 2009. ,, (Logo: h...OGO ) ,, "Since our last quarterly update, we h...
(Date:11/6/2009)...Call/ -- Cyberonics, Inc. (Nasdaq: CYBX ) today a...sults for the second quarter ended October 23, 200...esday, November 18, 2009 at 5:00 PM EST. The comp...e results on Thursday, November 19, 2009 at 9:00 A...ults Conference Call Instructions ,, To liste...
Breaking Medicine Technology:OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 2OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 3OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results 2Clinical Utility of Exhaled Nitric Oxide Highlighted By American Thoracic Society Panel 47603 1Clinical Utility of Exhaled Nitric Oxide Highlighted By American Thoracic Society Panel 47603 2EXTRA TV Features Tosca Renos Eat Clean Diets Libido Boosting Foods 47600 1EXTRA TV Features Tosca Renos Eat Clean Diets Libido Boosting Foods 47600 2Orexigen 28R 29 Therapeutics Announces Upcoming Data Presentations at American Diabetes Association and Endocrine Society Annual Scientific Meetings 12414 1Orexigen 28R 29 Therapeutics Announces Upcoming Data Presentations at American Diabetes Association and Endocrine Society Annual Scientific Meetings 12414 2
(Date:11/8/2009)... USAction this evening ...merica Act, which will make health care more affor...untable and increase access to health care for mil..."Teddy Roosevelt, FDR and Harry Truman would be pr... "Today,s vote ranks among our country,s proudest ...
(Date:11/8/2009)... The following was rele...escue Insurrecta Nex. ,, Mr. Terry and his ass... to keep child-killing by abortion out of any heal...This is a great first step to victory -- a touchdo...ghting ahead of us. Our rejoicing must be tempered...
(Date:11/8/2009)...e Passage of Health Care Reform Bill ,, Criti... coverage for all Americans ,, BALTIMORE, Nov....he United States House of Representatives passed c...strengthen Medicare for seniors and end discrimina...f Americans out of affordable health coverage. ,...
(Date:11/7/2009).... 7 Speaker Nancy Pelo...R. 3962, the Affordable Health Care for America Ac...onight. Below are the Speaker,s remarks. ,, "...ic moment for our nation and for American families...d political philosophy -- as far back as Teddy Roo...
(Date:11/7/2009)...man (CT), David A. Cook (GA), Louis J. Goodman (TX...red ,, CHICAGO, Nov. 7 /PRNewswire-USNewswire/...resented five medical society executive leaders wi... to the goals and ideals of the medical profession...al policy making meeting in Houston. ,, (Logo:...
Breaking Medicine News(10 mins):Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4Health News:AMA Honors Medical Society Executives 2
...hird quarter includes $1.8 million of first year ...mmercial products, DUBLIN, Calif., Oct. 29 Super...y dedicated to the discovery, rapid,development an...hs ended September 30, 2007. The Company reported...
...er reasons to avoid the habit, experts say , ... unhealthy in many other ways, but smoking does no...t cancer will have more aggressive or later-stage ... 35 years. , "Smoking did not affect treatment opt...
...ics Important to Detect, Diagnose and,Personalize ...or Congressional staff and the media on th...g diseases that disproportionately impact ...ght earlier and managed more effectively, ...
...The federal government has,approved all of BlueCro...vantage and Medicare Part D product offerings. Enr...ov. 15. BlueCross, products include two PPO plans...) Rx and MedBlue(SM) Rx,Plus. The plans include n...
... 29 Hovione,s Technology,Transfer Center (TTC) in...roval inspection by FDA. The inspection was carri...ficer at the US FDA Center for Drug Evaluation and...ad several positive,comments on our systems and in...
...nges Modern Psychology and Explodes Myths of ,Why ...NA BEACH, Fla., Oct. 29 Some children have a,gene...fficult to raise than,others. The notion of ,there.... For years, classical and modern,psychology sugge...
Other Medicine News:Health News:SuperGen Reports 2007 Third Quarter Financial Results 2Health News:SuperGen Reports 2007 Third Quarter Financial Results 3Health News:SuperGen Reports 2007 Third Quarter Financial Results 4Health News:SuperGen Reports 2007 Third Quarter Financial Results 5Health News:SuperGen Reports 2007 Third Quarter Financial Results 6Health News:SuperGen Reports 2007 Third Quarter Financial Results 7Health News:SuperGen Reports 2007 Third Quarter Financial Results 8Health News:SuperGen Reports 2007 Third Quarter Financial Results 9Health News:SuperGen Reports 2007 Third Quarter Financial Results 10Health News:Smoking Does Not Worsen Breast Cancer 2Health News:Smoking Does Not Worsen Breast Cancer 3Health News:AdvaMed Convenes Panel to Address Health Disparities 2Health News:FDA Inspects Hovione's Technology Transfer Center in New Jersey 2Health News:Bad Children Can Happen to Good Parents: A Survival Manual for Parents of Difficult Children by Norman E. Hoffman, Ph.D. 2Health News:Bad Children Can Happen to Good Parents: A Survival Manual for Parents of Difficult Children by Norman E. Hoffman, Ph.D. 3
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
Medicine Products: